Detalhe da pesquisa
1.
Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment.
Br J Surg
; 110(9): 1143-1152, 2023 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37471574
2.
Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1-2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial.
Ann Surg Oncol
; 29(9): 5732-5744, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35552930
3.
Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility.
Tumour Biol
; 39(4): 1010428317695023, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28378631
4.
Neoadjuvant chemotherapy and radical radiotherapy associated with cetuximab for laryngeal cancer in a pancreas and renal recipient.
Anticancer Drugs
; 27(5): 470-3, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26908347
5.
A Phase II study of olaparib in breast cancer patients: biological evaluation from a 'window of opportunity' trial.
Future Oncol
; 12(19): 2189-93, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27324108
6.
A network meta-analysis of everolimus plus exemestane versus chemotherapy in the first- and second-line treatment of estrogen receptor-positive metastatic breast cancer.
Breast Cancer Res Treat
; 152(1): 95-117, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26044370
7.
Breast cancer circulating biomarkers: advantages, drawbacks, and new insights.
Tumour Biol
; 36(9): 6653-65, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26307395
8.
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data.
Lancet Oncol
; 15(4): 406-14, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24636208
9.
Pure anti-tumor effect of zoledronic acid in naïve bone-only metastatic and locally advanced breast cancer: proof from the "biological window therapy".
Breast Cancer Res Treat
; 144(1): 113-21, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24469643
10.
Diagnostic tests based on gene expression profile in breast cancer: from background to clinical use.
Tumour Biol
; 35(9): 8461-70, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25048969
11.
De-Escalation Surgery in cT3-4 Breast Cancer Patients after Neoadjuvant Therapy: Predictors of Breast Conservation and Comparison of Long-Term Oncological Outcomes with Mastectomy.
Cancers (Basel)
; 16(6)2024 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38539504
12.
Comparison of Long-Term Oncological Results in Young Women with Breast Cancer between BRCA-Mutation Carriers Versus Non-Carriers: How Tumor and Genetic Risk Factors Influence the Clinical Prognosis.
Cancers (Basel)
; 15(16)2023 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37627205
13.
CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer.
Breast Cancer Res Treat
; 132(3): 819-31, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21960110
14.
The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.
Breast Cancer Res
; 13(1): R16, 2011 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-21291529
15.
"Overcoming breast cancer drug resistance with mTOR inhibitors". Could it be a myth or a real possibility in the short-term future?
Breast Cancer Res Treat
; 128(3): 599-606, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20945086
16.
Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study.
Breast Cancer Res Treat
; 128(1): 147-54, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21479926
17.
Is it time for everolimus-based combination in castration-resistant prostate cancer?
Future Oncol
; 12(16): 1849-52, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27250597
18.
Neo-Adjuvant Chemotherapy in Luminal, Node Positive Breast Cancer: Characteristics, Treatment and Oncological Outcomes: A Single Center's Experience.
Eur J Breast Health
; 17(4): 356-362, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34651115
19.
Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients.
Breast Cancer Res Treat
; 123(3): 795-804, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20680681
20.
Synergistic activity of letrozole and sorafenib on breast cancer cells.
Breast Cancer Res Treat
; 124(1): 79-88, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20054642